A 65-year-old man with heart failure (EF 30%) is on optimal medical therapy including lisinopril and carvedilol. He develops symptomatic hypotension with each dose of carvedilol. Which property of carvedilol, compared to metoprolol, accounts for this additional haemodynamic effect?
- A Carvedilol has intrinsic sympathomimetic activity causing vasodilation
- B Carvedilol has greater beta-2 blockade causing vascular constriction and reflex hypotension
- C Carvedilol additionally blocks alpha-1 adrenoceptors, causing peripheral vasodilation ✓
- D Carvedilol inhibits phosphodiesterase, increasing cAMP-mediated vasodilation
Explanation
Carvedilol is a non-selective beta-blocker (beta-1 and beta-2) that also blocks alpha-1 adrenoceptors, producing peripheral vasodilation. This combined action is responsible for additional blood pressure lowering and can cause symptomatic hypotension, especially when combined with ACE inhibitors. Metoprolol is a selective beta-1 blocker without alpha-blocking activity. Intrinsic sympathomimetic activity (ISA), seen with pindolol, would mitigate rather than cause hypotension.
Reference: KD Tripathi, Essentials of Medical Pharmacology, 8th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.